论文信息 - Enzalutamide, a prostate cancer therapeutic, downregulates TMPRSS2 in lung and reduces cellular entry of SARS-CoV-2 - 字舞流文

Enzalutamide, a prostate cancer therapeutic, downregulates TMPRSS2 in lung and reduces cellular entry of SARS-CoV-2

D. Leach | W. Barclay | L. Yates | C. Bevan | A. Mohr | G. Brooke | R. Zwacka | A. Isac | E. S. Giotis